17 May 2024

To,

Mr. Hafiz Maqsood Munshi

Unit Head, Listed Companies Compliance-RAD.

Pakistan Stock Exchange Limited.

Stock Exchange Building,

Stock Exchange Road,

Karachi.

GlaxoSmithKline

Pakistan Limited

35-Dockyard Road,

West Wharf,

Karachi - 74000,

Pakistan

T +92 21 111 475 725

Subject: Unusual Movement in the Price of the shares of GlaxoSmithKline Pakistan Limited ("GLAXO")

Dear Sir,

Reference to your letter No GEN - 692 dated May 15, 2024, regarding subject and as requested we would like to inform you that we are not aware of any matter and/or development that may have resulted in the increase in price of 'Glaxo', which has not been previously disclosed to the market through PUCARS.

We trust the above adequately address your query.

Your truly,

________________

Salman Taimur

GlaxoSmithKline Pakistan Limited

Company Secretary

Registered in Pakistan, registration no. K-304 of 1948-49.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

GSK - GlaxoSmithKline Pakistan Ltd. published this content on 20 May 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 May 2024 04:49:05 UTC.